IRIS
BOSIA, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.597
EU - Europa 1.846
NA - Nord America 1.773
SA - Sud America 518
AF - Africa 47
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.798
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.670
SG - Singapore 1.083
CN - Cina 810
IT - Italia 479
BR - Brasile 448
SE - Svezia 399
HK - Hong Kong 367
RO - Romania 267
DE - Germania 147
RU - Federazione Russa 115
GB - Regno Unito 104
VN - Vietnam 99
IN - India 75
CA - Canada 61
FI - Finlandia 57
FR - Francia 47
NL - Olanda 46
PL - Polonia 45
ES - Italia 40
TR - Turchia 36
AR - Argentina 30
IE - Irlanda 29
MX - Messico 27
AT - Austria 22
JP - Giappone 22
BD - Bangladesh 17
ZA - Sudafrica 16
CO - Colombia 13
KR - Corea 12
EG - Egitto 11
PK - Pakistan 11
AU - Australia 10
EC - Ecuador 10
ID - Indonesia 10
LT - Lituania 10
IQ - Iraq 6
IR - Iran 6
CH - Svizzera 5
MA - Marocco 5
PT - Portogallo 5
BE - Belgio 4
CL - Cile 4
IL - Israele 4
JO - Giordania 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PE - Perù 4
PH - Filippine 4
PY - Paraguay 4
SA - Arabia Saudita 4
TN - Tunisia 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
GR - Grecia 3
HR - Croazia 3
JM - Giamaica 3
LB - Libano 3
NP - Nepal 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
LY - Libia 2
PA - Panama 2
SC - Seychelles 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
EU - Europa 1
GT - Guatemala 1
KG - Kirghizistan 1
KI - Kiribati 1
NO - Norvegia 1
OM - Oman 1
SV - El Salvador 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.798
Salva come PNG Salva come JPEG
Città #
Singapore 502
Hong Kong 356
Dallas 222
Ashburn 219
Shanghai 196
Beijing 151
Hefei 136
Milan 121
Princeton 102
Lawrence 101
New York 81
São Paulo 58
Munich 57
Los Angeles 51
Boardman 47
Moscow 46
Helsinki 34
Warsaw 34
Ho Chi Minh City 33
Rome 31
Dublin 30
Montreal 25
Atlanta 24
Brooklyn 24
Chennai 24
Denver 22
Hanoi 22
Tokyo 21
Orem 20
London 19
The Dalles 19
Pittsburgh 18
Poplar 18
Pune 18
Seattle 18
Turku 18
Frankfurt am Main 17
Santa Clara 17
Stockholm 17
Guangzhou 15
Ankara 14
San Francisco 14
Houston 13
Nuremberg 13
Vienna 13
Boston 12
Council Bluffs 12
Genoa 12
Toronto 12
Amsterdam 11
Istanbul 11
Johannesburg 11
Belo Horizonte 10
Chicago 10
Rio de Janeiro 10
Secaucus 10
Curitiba 9
Phoenix 9
Apodaca 8
Brasília 8
Brescia 8
Manchester 8
Washington 8
City of London 7
Fortaleza 7
Guarulhos 7
Lentate sul Seveso 7
Mexico City 7
Mumbai 7
Turin 7
Cairo 6
Columbus 6
Dalton 6
Dhaka 6
Ottawa 6
Charlotte 5
Ferrara 5
Guwahati 5
Gwangjin-gu 5
Naples 5
Ribeirão Preto 5
San Jose 5
Santander 5
St Louis 5
Tianjin 5
Xi'an 5
Auckland 4
Bogotá 4
Bologna 4
Brisbane 4
Bắc Ninh 4
Calgary 4
Campinas 4
Cesano Boscone 4
Chongqing 4
Concord 4
Duque de Caxias 4
Florence 4
Glasgow 4
Guayaquil 4
Totale 3.420
Salva come PNG Salva come JPEG
Nome #
Clozapine to N-Desmethylclozapine ratio in treatment resistant schizophrenia: clinical implications from psychopathology to cognition 334
Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes 194
Assessment of pragmatic abilities and cognitive substrates (APACS) brief remote: a novel tool for the rapid and tele-evaluation of pragmatic skills in Italian 108
Functional and structural brain correlates of theory of mind and empathy deficits in schizophrenia 108
Valutazione del funzionamento cognitivo ‘trasferibili’ alla pratica clinica: la brief assessment of cognition scale (BACS) e la schizophrenia cognition rating scale (SCORS) 102
'Theory' of mind impairment in patients affected by schizophrenia and in their parents 100
M51. EFFICACY OF “PRAGMACOM TRAINING” IN SCHIZOPHRENIA: A RCT ON A NOVEL PRAGMATIC INTERVENTION 97
It is time to address language disorders in schizophrenia: a RCT on the efficacy of a novel training targeting the pragmatics of communication (PragmaCom) 91
The cognitive architecture of verbal humor in schizophrenia 90
Cognitive Remediation for Inpatients With Schizophrenia: Effects of a Brief and Intensive Training 86
Get up! Functional mobility and metabolic syndrome in chronic schizophrenia: Effects on cognition and quality of life 82
Modeling the interplay of age at onset and sex on cognition in Schizophrenia 80
Cognitive reserve profiles are associated with outcome in schizophrenia 77
Mind the past: A systematic review on psychological autopsy 75
Adult Consequences of Neurodevelopmental Disorders 75
Psychotic Disorders 73
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy 73
Combined effect of treatment-resistance and autistic traits on sociocognitive abilities in schizophrenia 72
Machine Learning and Criminal Justice: A Systematic Review of Advanced Methodology for Recidivism Risk Prediction 72
Eyes wide open: A systematic review of the association between insomnia and aggression in forensic contexts 69
Targeting quality of life in schizophrenia: the fil rouge between metabolic syndrome and anxiety 68
Deconstructing heterogeneity in schizophrenia through language: a semi-automated linguistic analysis and data-driven clustering approach 68
Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex 67
Communicative-pragmatic abilities mediate the relationship between cognition and daily functioning in schizophrenia 66
A leopard cannot change its spots: A novel pragmatic account of concretism in schizophrenia 65
Disentangling Cognitive Heterogeneity in Psychotic Spectrum Disorders 64
Cognitive remediation in schizophrenia: What happens after 10 years? 63
Catechol-O-methyltransferase (COMT) genotype biases neural correlates of empathy and perceived personal distress in schizophrenia 63
Association study of COMT Val108/158Met polymorphism and treatment response to haloperidol, risperidone and clozapine 63
Obsessive-compulsive symptoms moderates the effects of cognitive functioning on quality of life in clozapine-treated schizophrenia 62
ADDing a piece to the puzzle of cognition in schizophrenia 62
Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions 60
Organic Mental Disorders and Psychiatric Issues in the Elderly 60
9-OH risperidone response in risperidone poor responders: An open study of drug response concordance 58
Influence of catechol-O-methyltransferase Val(158) Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia 58
Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy 58
Dysconnection in schizophrenia: Filling the dots from old to new evidence 57
Self-awareness of cognitive functioning in schizophrenia: Patients and their relatives 57
Cognition in Schizophrenia: Modeling the Interplay between Interleukin-1β C-511T Polymorphism, Metabolic Syndrome, and Sex 57
Longitudinal course of cognition in schizophrenia: Does treatment resistance play a role? 57
Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies 56
Catechol-O-methyltransferase and saitohin gene polymorphism interaction: Effect on executive functions in schizophrenia 55
Non-Pharmacological Treatments 54
Association study of GSK-3 beta-50T/C polymorphism with haloperidol resistance in schizophrenia. 54
Association study of GSK-3 beta-50T/C polymorphism with executive performances in schizophrenia 54
Achieving recovery in patients with schizophrenia through psycho-social interventions: A retrospective study 54
Functional benefits of co-occurring autistic symptoms in schizophrenia is delimited by symptom severity 54
Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling 53
Is longer treatment better? A comparison study of 3 versus 6 months cognitive remediation in schizophrenia 53
Factors affecting cognitive remediation outcome in schizophrenia: The role of treatment resistance 52
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise 52
Eyes wide open: A systematic review of the association between insomnia and aggression in forensic contexts 52
Medium-term effectiveness of a new, prolonged-release, atypical antipsychotic: An objectives-based observational study [Effectiveness a medio termine di un nuovo antipsicotico atipico a rilascio prolungato: Uno studio osservazionale per obbiettivi] 51
Association study of a functional cathechol-O-methyltransferase polymorphism and cognitive rernediation in schizophrenia 51
Substance-Related Disorders 50
Biochemical targets of tamoxifen and lithium in an animal model of mania 50
Can patients with schizophrenia have good mentalizing skills? Disentangling heterogeneity of theory of mind 50
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability 48
HTTLPR functional polymorphism in schizophrenia: Executive functions vs. sustained attention dissociation 47
Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia 46
M202. SEX-RELATED DIFFERENCES IN CLOZAPINE SIDE EFFECTS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA 46
Antipsychotics, metabolic syndrome and schizophrenia: investigating the role of SREBF polymorphisms 44
Combined neurocognitive and metacognitive rehabilitation in schizophrenia: Effects on bias against disconfirmatory evidence 44
Factors affecting cognitive remediation response in schizophrenia: The role of COMT gene and antipsychotic treatment 43
Computer-aided neurocognitive remediation in schizophrenia: Durability of rehabilitation outcomes in a follow-up study 43
Exploring functioning in schizophrenia: Predictors of functional capacity and real-world behaviour 43
On the Implementation of Computerized Adaptive Observations for Psychological Assessment 43
CYP450 genotypes: metabolism and efficacy of the antidepressant mirtazapine 42
Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances 42
White matter integrity, clinical symptoms and quality of life in schizophrenia: a DTI study 41
Interleukin-1 beta, cognition and metabolic syndrome in schizophrenia 41
The role of premorbid adjustment in schizophrenia: Focus on cognitive remediation outcome 41
Pragmatic abilities across symptoms dimensions in schizophrenia 40
VALUTAZIONI DEL FUNZIONAMENTO COGNITIVO “TRASFERIBILI” ALLA PRATICA CLINICA: LA BRIEF ASSESSMENT OF COGNITION SCALE (BACS) E LA SCHIZOPHRENIA COGNITION RATING SCALE (SCORS) 40
Exploring predictors of work competence in schizophrenia: The role of theory of mind 40
COMT Val158Met and 5-HT1A-R-1019 C/G polymorphisms: effects on the negative symptom response to clozapine 40
Integrated cognitive remediation and standard rehabilitation therapy in patients of schizophrenia: Persistence after 5years 38
Improving Cognition to Increase Treatment Efficacy in Schizophrenia: Effects of Metabolic Syndrome on Cognitive Remediation's Outcome 38
S67. TREATMENT-RESISTANCE AFFECTS LONG-TERM COGNITIVE TRAJECTORIES IN SCHIZOPHRENIA: A LONGITUDINAL STUDY 38
Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art 38
Combined social cognitive and neurocognitive rehabilitation strategies in schizophrenia: neuropsychological and psychopathological influences on Theory of Mind improvement. 37
The association of autistic traits with Theory of Mind and its training efficacy in patients with schizophrenia 37
Treatment-resistance as a predictor of cognitive remediation outcome in schizophrenia 36
Daily Functioning in Schizophrenia: Is There Room for Anxiety? 36
Psychedelics and schizophrenia: a double-edged sword 36
Effect of glutamate transporter EAAT2 gene variants and gray matter deficits on working memory in schizophrenia 35
Epigenetics in schizophrenia and association with antipsychotic response to clozapine: preliminary findings 35
Neurobiology of cognitive remediation in schizophrenia: Effects of EAAT2 polymorphism 35
Theory of mind and emotion processing training for patients with schizophrenia: Preliminary findings 34
Evaluation of the role of HTR1A C-1019G polymorphism in antidepressant efficacy: a meta-analysis 34
Exploring the effect of genetic variability of adducins on cognition in schizophrenia 34
The role of genetics in cognitive remediation in schizophrenia: A systematic review 34
Melatonin and aggressive behavior: A systematic review of the literature on preclinical and clinical evidence 34
Effect of 5-HT1a and catechol-O-methyltransferase gene polymorphisms on negative symptom response to clozapine 33
Self-awareness of cognitive functioning in schizophrenia: patients and their relatives 33
The Influence of Premorbid Adjustment and Autistic Traits on Social Cognitive Dysfunction in Schizophrenia 33
Stability and Generalization of Combined Theory of Mind and Cognitive Remediation Interventions in Schizophrenia: Follow-Up Results 33
Theory of mind and stereotypic behavior promote daily functioning in patients with schizophrenia 33
COMMUNICATION IN SCHIZOPHRENIA, BETWEEN PRAGMATICS, COGNITION AND SOCIAL COGNITION 32
Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia 31
Totale 5.837
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 8 3 0 0 0 0 0
2021/202284 0 0 0 20 8 4 2 6 12 6 13 13
2022/2023792 240 133 58 7 47 110 34 52 50 15 23 23
2023/2024579 36 37 72 63 62 82 12 51 2 25 29 108
2024/20252.539 272 55 70 125 95 190 497 166 388 272 202 207
2025/20262.904 550 463 271 829 638 153 0 0 0 0 0 0
Totale 6.943